IT1299173B1 - The topical ophthalmic use of thalidomide and its derivatives in the medicinal composition for antiangiogenetic activities - Google Patents

The topical ophthalmic use of thalidomide and its derivatives in the medicinal composition for antiangiogenetic activities

Info

Publication number
IT1299173B1
IT1299173B1 IT98RM000271A ITRM980271A IT1299173B1 IT 1299173 B1 IT1299173 B1 IT 1299173B1 IT 98RM000271 A IT98RM000271 A IT 98RM000271A IT RM980271 A ITRM980271 A IT RM980271A IT 1299173 B1 IT1299173 B1 IT 1299173B1
Authority
IT
Italy
Prior art keywords
antiangiogenetic
thalidomide
activities
derivatives
topical ophthalmic
Prior art date
Application number
IT98RM000271A
Other languages
Italian (it)
Inventor
Ferdinando Ippolito
Siro Passi
Carlo Aldo Di
Decimo Guarnieri
Original Assignee
Ferdinando Ippolito
Passi Sirio
Carlo Aldo Di
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferdinando Ippolito, Passi Sirio, Carlo Aldo Di filed Critical Ferdinando Ippolito
Priority to IT98RM000271A priority Critical patent/IT1299173B1/en
Publication of ITRM980271A0 publication Critical patent/ITRM980271A0/en
Publication of ITRM980271A1 publication Critical patent/ITRM980271A1/en
Application granted granted Critical
Publication of IT1299173B1 publication Critical patent/IT1299173B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The topical ophthalmic use of thalidomide (α-phthalimidoglutarimide acid or N-phthaloyl glutarimide) is the appropriate composition or the ocular pathology that responds to the antiangiogenetic activities.
IT98RM000271A 1998-04-27 1998-04-27 The topical ophthalmic use of thalidomide and its derivatives in the medicinal composition for antiangiogenetic activities IT1299173B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT98RM000271A IT1299173B1 (en) 1998-04-27 1998-04-27 The topical ophthalmic use of thalidomide and its derivatives in the medicinal composition for antiangiogenetic activities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98RM000271A IT1299173B1 (en) 1998-04-27 1998-04-27 The topical ophthalmic use of thalidomide and its derivatives in the medicinal composition for antiangiogenetic activities

Publications (3)

Publication Number Publication Date
ITRM980271A0 ITRM980271A0 (en) 1998-04-27
ITRM980271A1 ITRM980271A1 (en) 1999-10-27
IT1299173B1 true IT1299173B1 (en) 2000-02-29

Family

ID=11405868

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98RM000271A IT1299173B1 (en) 1998-04-27 1998-04-27 The topical ophthalmic use of thalidomide and its derivatives in the medicinal composition for antiangiogenetic activities

Country Status (1)

Country Link
IT (1) IT1299173B1 (en)

Also Published As

Publication number Publication date
ITRM980271A0 (en) 1998-04-27
ITRM980271A1 (en) 1999-10-27

Similar Documents

Publication Publication Date Title
NO975747D0 (en) Peptidyl heterocycles for use in the treatment of thrombin-related deficiencies
BR9406209A (en) Heterocyclic derivatives in the treatment of ischemia and related diseases
DE69416124T2 (en) COMPOSITION FOR CLEANING AND MOISTURIZING CONTACT LENSES
FR2750599B1 (en) NOVEL COSMETIC COMPOSITIONS COMPRISING LIQUID CRYSTAL COLORING AGENTS AND THEIR USE
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
HK1045986A1 (en) Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders.
HUP9601161A3 (en) Use of retinoids in cosmetic compositions or for the manufacture of pharmaceutical compositions
ZA978557B (en) Process for the determination of APP secretase modulators and the use thereof as agents in the treatment of a Alzheimer's disease.
EP0879597A4 (en) Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same
EE04055B1 (en) Compounds and compositions for the treatment of diseases associated with serine protease activity, in particular tryptase activity, and their use
NO20030295D0 (en) Use of derivatives of valproic acid and 2-valproic acid amides for the treatment of manners in bipolar disorders
NZ307958A (en) Benzisoxazole and indazole derivatives as long acting antipsychotic agents and particularly in the treatment of schizophrenia
AU1920501A (en) The use of caspase 9 inhibitors to treat ocular neural pathology
GB8827539D0 (en) Ophthalmic ultra violet absorptive emollient
EP0437026A3 (en) Use of tandospirone in the treatment of depression
MX9505180A (en) Use of a p substance antagonist for the obtention of a pharmaceutical composition for ocular or palpebral pruritus and dysesthesias treatment.
IT1299173B1 (en) The topical ophthalmic use of thalidomide and its derivatives in the medicinal composition for antiangiogenetic activities
DE69721484D1 (en) NUCLEOSIDE DERIVATIVES IN COMBINATION PREPARATIONS FOR THE TREATMENT OF HSV DISEASES
NO913774L (en) CYCLOHEXYLPHENYL PYRIMIDINES, PROCEDURE FOR THE PREPARATION AND USE OF THEREOF IN LIQUID CRYSTALLINE MIXTURES
FI970165A (en) Use of (S) -atenosyl-L-methionine (SAMe) and its physiologically acceptable salts for the treatment of reperfusion injury due to transient focal ischemia
BR9704964A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of some psychomotor and psycho-intellectual disorders
EE9400039A (en) Composition for ophthalmic use
AU1021492A (en) Use of carrageenans in topical ophthalmic compositions
EP0449427A3 (en) Use of an antihistamine in the treatment of alcohol intoxication
GR77250B (en)

Legal Events

Date Code Title Description
0001 Granted